New pill for acne begins human testing

NCT ID NCT06989840

Recruiting now Disease control Sponsor: Sagimet Biosciences Inc. Source: ClinicalTrials.gov ↗

Summary

This early-stage study is testing the safety of a new oral medication called TVB-3567 for acne. Researchers will give healthy adults with and without moderate to severe acne different doses of the drug to see how their bodies handle it and check for side effects. The study will also examine whether taking the medication with food affects how it works in the body.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACNE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Celerion, Inc.
COMPLETED

Tempe, Arizona, 85283, United States
Nucleus Network
RECRUITING

Melbourne, Victoria, 3004, Australia

Conditions

Explore the condition pages connected to this study.

ACNE